Scinai Immunotherapeutics Ltd. Stock Analysis & AI Score
Scinai Immunotherapeutics Ltd. (SCNI) has an ST Score of 32.6 (C-), driven by its Growth (A+) and held back by its Momentum (F). SCNI last traded at $1.86.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Scinai Immunotherapeutics Ltd. (SCNI) has an ST Score of 32.6 (C-), driven by its Growth (A+) and held back by its Momentum (F). SCNI last traded at $1.86.
- Strongest
- GrowthA+
- Weakest
- MomentumF
All factor grades
- GrowthA+
- ProfitabilityB
- ValuationD
- Financial StrengthD-
- MomentumF
- Piotroski2/9
Contact
SCNI stock: frequently asked questions
What is SCNI's ST Score?
Scinai Immunotherapeutics Ltd. (SCNI) has an ST Score of 32.6 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SCNI a buy, hold, or sell?
Our ST Score grades it C- (32.6/100). The ST Score is a data-driven signal, not a recommendation.
What are SCNI's factor grades?
Valuation D, Profitability B, Financial Strength D-, Momentum F, Growth A+.
What is SCNI's valuation grade?
Scinai Immunotherapeutics Ltd. (SCNI) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SCNI's growth grade?
Scinai Immunotherapeutics Ltd. (SCNI) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SCNI's profitability grade?
Scinai Immunotherapeutics Ltd. (SCNI) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SCNI's financial strength grade?
Scinai Immunotherapeutics Ltd. (SCNI) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is SCNI's Piotroski score?
Scinai Immunotherapeutics Ltd. (SCNI) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.